Allergic contact dermatitis

European Journal of Dermatology

Volumn 14, Issue 5, 2004, Pages 284-295

  Saint Mezard, Pierre ^a   Rosieres, Aurore ^a   Krasteva, Maya ^a   Berard, Frédéric ^a,b   Dubois, Bertrand ^a   Kaiserlian, Dominique ^b   Nicolas, Jean François ^a,b  

^a University Lyon i   (France)

^b Department of Clinical Immunology   (France)

Author keywords

CD4 regulatory T cells; CD8 T cells; Contact dermatitis; Contact sensitivity; CTL; Haptens; Tolerance

Indexed keywords

ANESTHETIC AGENT; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ANTISENSE OLIGONUCLEOTIDE; CELL ADHESION MOLECULE; CORTICOSTEROID; CYTOKINE ANTIBODY; CYTOKINE RECEPTOR; DISULFIRAM; HAPTEN; IMMUNOGLOBULIN G2B; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; INTERLEUKIN 2; LACTAM DERIVATIVE; PHOTOSENSITIZING AGENT; PROTEIN INHIBITOR;

CELL MATURATION; CELL MIGRATION; CELL POLARITY; CLINICAL TRIAL; CONTACT SENSITIVITY; CYTOTOXICITY; DELAYED HYPERSENSITIVITY; DENDRITIC CELL; DRUG EFFECT; ECZEMA; EFFECTOR CELL; ERYTHEMA; HUMAN; IMMUNE RESPONSE; IRRITANT DERMATITIS; NONHUMAN; PATHOPHYSIOLOGY; PRURITUS; REVIEW; SENSITIZATION; SIDE EFFECT; SKIN ALLERGY; SKIN INFLAMMATION; T LYMPHOCYTE;

DERMATITIS, ALLERGIC CONTACT; HUMANS;

EID: 4544259671     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (142)

1. Uter W, Schnuch A, Geier J, Frosch PJ. Epidemiology of contact dermatitis. The information network of departments of dermatology (IVDK) in Germany. Eur J Dermatol 1998; 8: 36-40.
2. Krasteva M, et al. Contact dermatitis II. Clinical aspects and diagnosis. Eur J Dermatol 1999; 9: 144-59.
3. Krasteva M, et al. Contact dermatitis I. Pathophysiology of contact sensitivity. Eur J Dermatol 1999; 9: 65-77.
4. Lepoittevin J, Leblond I. Hapten-peptide T cell receptor interactions: molecular basis for the recognition of haptens by T lymphocytes. Eur J Dermatol 1997; 7: 151-4.
5. Dupuis GB. Nature of hapten-protein interactions. Chemically reactive function in haptens and proteins, in allergic contact dermatitis to simple chemicals. A molecular approach. New-York: Ed Marcel Dekker, Inc.: 1982.
6. Berard F, Marty JP, Nicolas JF. Allergen penetration through the skin. Eur J Dermatol 2003; 13: 324-30.
7. Dupuis G. Studies on poison ivy. In vitro lymphocyte transformation by urushiol-protein conjugates. Br J Dermatol 1979; 101: 617-24.
8. Saloga J, Knop J, Kolde G. Ultrastructural cytochemical visualization of chromium in the skin of sensitized guinea pigs. Arch Dermatol Res 1988; 280: 214-9.
9. Anderson C, et al. Metabolic requirements for induction of contact hypersensitivity to immunotoxic polyaromatic hydrocarbons. J Immunol 1995; 155: 3530-7.
10. Martin S, Ortmann B, Pflugfelder U, Birsner U, Weltzien HU. Role of hapten-anchoring peptides in defining hapten-epitopes for MHC-restricted cytotoxic T cells. Cross-reactive TNP-determinants on different peptides. J Immunol 1992; 149: 2569-75.
11. Vigon M, Girardin P, Adessi B, Laurent R. Late reading of patch tests. Eur J Dermatol 1997; 7: 574-6.
12. Saint-Mezard P, et al. Afferent and efferent phases of allergic contact dermatitis (ACD) can be induced after a single skin contact with haptens: evidence using a mouse model of primary ACD. J Invest Dermatol 2003; 120: 641-7.
13. Toews GB, Bergstresser PR, Streilein JW. Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB. J Immunol 1980; 124: 445-53.
14. Lynch DH, Gurish MF, Doynes RA. Relationship between epidermal Langerhans cell density ATPase activity and the induction of contact hypersensitivity. J Immunol 1981; 126: 1892-7.
15. Ptak W, Rozycka D, Askenose PW, Gershon RK. Role of antigen-presenting cells in the development and persistence of contact hypersensitivity. J Exp Med 1980; 151: 362-75.
16. Tomaki K, Fujiwara H, Levy RB, Shearer GM, Kotz SI. Hapten specific TNP-reactive cytotoxic effector cells using epidermal cells as targets. J Invest Dermatol 1981; 77: 225-9.
17. Girolomoni G, et al. Establishment of a cell line with features of early dendritic cell precursors from fetal mouse skin. Eur J Immunol 1995; 25: 2163-9.
18. Caux C. Pathways of development of human dendritic cells. Eur J Dermatol 1998; 8: 375-84.
19. Kurimoto I, Grammer SF, Shimizu T, Nakamura T, Streilein JW. Role of F4/80+ cells during induction of hapten-specific contact hypersensitivity. Immunology 1995; 85: 621-9.
20. Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003; 19: 71-82.
21. Taylor PR, Gordon S. Monocyte heterogeneity and innate immunity. Immunity 2003; 19: 2-4.
22. Frey JR, Wenk P. Experimental studies on the pathogenesis of contact eczema in the guinea-pig. Int Arch Allergy Appl Immunol 1957; 11: 81-100.
23. Macatonia SE, Edwards AJ, Knight SC. Dendritic cells and the initiation of contact sensitivity to fluorescein isothiocyanate. Immunology 1986; 59: 509-14.
24. Macatonia SE, Knight SC, Edwards AJ, Griffiths S, Fryer P. Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies. J Exp Med 1987; 166: 1654-67.
25. Kamath AT, Henri S, Battye F, Tough DF, Shortman K. Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs. Blood 2002; 100: 1734-41.
26. Enk AH, Angeloni VL, Udey MC, Katz SI. An essential role for Langerhans cell-derived IL-1 beta in the initiation of primary immune responses in skin. J Immunol 1993; 150: 3698-704.
27. Borkowski TA, et al. Expression of E-cadherin by murine dendritic cells: E-cadherin as a dendritic cell differentiation antigen characteristic of epidermal Langerhans cells and related cells. Eur J Immunol 1994; 24: 2767-74.
28. Schwarzenberger K, Udey MC. Contact allergens and epidermal proinflammatory cytokines modulate Langerhans cell E-cadherin expression in situ. J Invest Dermatol 1996; 106: 553-8.
29. Wang B, et al. Tumour necrosis factor receptor II (p75) signalling is required for the migration of Langerhans' cells. Immunology 1996; 88: 284-8.
30. Wang B, et al. Depressed Langerhans cell migration and reduced contact hypersensitivity response in mice lacking TNF receptor p75. J Immunol 1997; 159: 6148-55.
31. Tang A, Amagai M, Granger LG, Stanley JR, Udey MC. Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature 1993; 361: 82-5.
32. Dieu MC, et al. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med 1998; 188: 373-86.
33. Kobayashi Y, Matsumoto M, Kotani M, Makino T. Possible involvement of matrix metalloproteinase-9 in Langerhans cell migration and maturation. J Immunol 1999; 163: 5989-93.
34. Gearing AJ, et al. Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature 1994; 370: 555-7.
35. Cyster JG. Chemokines and the homing of dendritic cells to the T cell areas of lymphoid organs. J Exp Med 1999; 189: 447-50.
36. Ngo VN, et al. Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J Exp Med 1999; 189: 403-12.
37. Engeman TM, Gorbachev AV, Gladue RP, Heeger PS, Fairchild RL. Inhibition of functional T cell priming and contact hypersensitivity responses by treatment with anti-secondary lymphoid chemokine antibody during hapten sensitization. J Immunol 2000; 164: 5207-14.
38. Martin-Fontecha A, et al. Regulation of dendritic cell migration to the draining lymph node: impact an T lymphocyte traffic and priming. J Exp Med 2003; 198: 615-21.
39. Becker D, Neiss U, Neis S, Reske K, Knop J. Contact allergens modulate the expression of MHC class II molecules on murine epidermal Langerhans cells by endocytotic mechanisms. J Invest Dermatol 1992; 98: 700-5.
40. Becker D, Mohamadzadeh M, Reske K, Knop J. Increased level of intracellular MHC class II molecules in murine Langerhans cells following in vivo and in vitro administration of contact allergens. J Invest Dermatol 1992; 99: 545-9.
41. Pierre P, Mellman I. Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell 1998; 93: 1135-45.
42. Garrett WS, et al. Developmental control of endocytosis in dendritic cells by Cdc42. Cell 2000; 102: 325-34.
43. Ruedl C, Koebel P, Karjalainen K. In vivo-matured Langerhans cells continue to take up and process native proteins unlike in vitro-matured counterparts. J Immunol 2001; 166: 7178-82.
44. Waksman BH. Cellular hypersensitivity immunity: inflammation and cytotoxicity. Philadelphia: Saunders, 1978. p. 173-218.
45. Weltzien HU, et al. T cell immune responses to haptens. Structural models for allergic and autoimmune reactions. Toxicology 1996; 107: 141-51.
46. von Bonin A, Ortmonn B, Martin S, Weltzien HU. Peptide-conjugated hapten groups are the major antigenic determinants for trinitrophenyl-specific cytotoxic T cells. Int Immunol 1992; 4: 869-74.
47. Kohler J, Hartmonn U, Grimm R, Pflugfelder U, Weltzien HU. Carrier-independent hapten recognition and promiscuous MHC restriction by CD4+ T cells induced by trinitrophenylated peptides. J Immunol 1997; 158: 591-7.
48. Cavani A, Hackett CJ, Wilson KJ, Rothbard JB, Katz SI. Characterization of epitopes recognized by hapten-specific CD4+ T cells. J Immunol 1995; 154: 1232-8.
49. Gamerdinger K, et al. A new type of metal recognition by human T cells: contact residues for peptide-independent bridging of T cell receptor and major histocompatibility complex by nickel. J Exp Med 2003; 197: 1345-53.
50. Sinigaglia F. The molecular basis of metal recognition by T cells. J Invest Dermatol 1994; 102: 398-401.
51. Martin S, von Bonin A, Fessler C, Pflugfelder U, Weltzien HU. Structural complexity of antigenic determinants for class I MHC-restricted, hapten-specific T cells. Two qualitatively differing types of H-2Kb-restricted TNP epitopes. J Immunol 1993; 151: 678-87.
52. Kalish RS, Wood JA, LaPorte A. Processing of urushiol (poison ivy) hapten by both endogenous and exogenous pathways for presentation to T cells in vitro. J Clin Invest 1994; 93: 2039-47.
53. Nalefski EA, Rao A. Nature of the ligand recognized by a hapten- and carrier-specific, MHC-restricted T cell receptor. J Immunol 1993; 150: 3806-16.
54. Reiser H, Schneeberger EE. Expression and function of B7-1 and B7-2 in hapten-induced contact sensitivity. Eur J Immunol 1996; 26: 880-5.
55. Symington FW, Brady W, Linsley PS. Expression and function of B7 on human epidermal Langerhans cells. J Immunol 1993; 150: 1286-95.
56. Kondo S, Kooshesh F, Wang B, Fujisawa H, Sauder DN. Contribution of the CD28 molecule to allergic and irritant-induced skin reactions in CD28 -/- mice. J Immunol 1996; 157: 4822-9.
57. Xu H, Heeger PS, Fairchild RL. Distinct roles for B7-1 and B7-2 determinants during priming of effector CD8+ Tc1 and regulatory CD4+ Th2 cells for contact hypersensitivity. J Immunol 1997; 159: 4217-26.
58. Fraser JD, Irving BA, Crabtree GR, Weiss A. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science 1991; 251: 313-6.
59. Boise LH, et al. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity 1995; 3: 87-98.
60. Adema GJ, et al. A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature 1997; 387: 713-7.
61. Geijtenbeek TB, et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000; 100: 575-85.
62. Krawczyk C, et al. Vav1 controls integrin clustering and MHC/peptide-specific cell adhesion to antigen-presenting cells. Immunity 2002; 16: 331-43.
63. Monks CR, Freiberg BA, Kupfer H, Sciaky N, Kupfer A. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature 1998; 395: 82-6.
64. Chen AI, et al. Ox40-ligand has a critical costimulatory role in dendritic cell: T cell interactions. Immunity 1999; 11: 689-98.
65. Sad S, Marcotte R, Mosmann TR. Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines. Immunity 1995; 2: 271-9.
66. Hahn S, et al. Down-modulation of CD4+ T helper type 2 and type 0 cells by T helper type 1 cells via Fas/Fas-ligand interaction. Eur J Immunol 1995; 25: 2679-85.
67. Li L, Sad S, Kagi D, Mosmann TR. CD8+Tc1 and Tc2 cells secrete distinct cytokine patterns in vitro and in vivo but induce similar inflammatory reactions. J Immunol 1997; 158: 4152-61.
68. Maldonado-Lopez R, Maliszewski C, Urbain J, Moser M. Cytokines regulate the capacity of CD8+alpha(+) and CD8+alpha(-) dendritic cells to prime Th1/Th2 cells in vivo. J Immunol 2001; 167: 4345-50.
69. Cella M, Facchetti F, Lanzavecchia A, Colanna M. Plasmacytoid dendritic cells activated by influenza virus and CD4+0L drive a potent TH1 polarization. Nat Immunol 2000; 1: 305-10.
70. MacDonald AS, Straw AD, Bauman B, Pearce EJ. CD8+- dendritic cell activation status plays an integral role in influencing Th2 response development. J Immunol 2001; 167: 1982-8.
71. Ardavin C, et al. Origin and differentiation of dendritic cells. Trends Immunol 2001; 22: 691-700.
72. Soumelis V, et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 2002; 3: 673-80.
73. Bour H, et al. Major histocompatibility complex class I-restricted CD8+ T cells and class II-restricted CD4+ T cells, respectively, mediate and regulate contact sensitivity to dinifrofluorobenzene. Eur J Immunol 1995; 25: 3006-10.
74. Xu H, Dilulio NA, Fairchild RL. T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma-producing (Tc1) effector CD8+ T cells and interleukin (II) 4/II-10-producing (Th2) negative regulatory CD4+ T cells. J Exp Med 1996; 183: 1001-12.
75. Gorbochev AV, Dilulio NA, Fairchild RL. IL-12 augments CD8+ T cell development for contact hypersensitivity responses and circumvents anti-CD154 antibody-mediated inhibition. J Immunol 2001; 167: 156-62.
76. Gocinski BL, Tigelaar RE. Roles of CD4+ and CD8+ T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion. J Immunol 1990; 144: 4121-8.
77. Bouloc A, Cavani A, Katz SI. Contact hypersensitivity in MHC class II-deficient mice depends on CD8+ T lymphocytes primed by immunostimulating Langerhans cells. J Invest Dermatol 1998; 111: 44-9.
78. Kolesaric A, Stingl G, Elbe-Burger A. MHC class I+/II- dendritic cells induce hapten-specific immune responses in vitro and in vivo. J Invest Dermatol 1997; 109: 580-5.
79. Krasteva M, et al. Dual role of dendritic cells in the induction and down-regulation of antigen-specific cutaneous inflammation. J Immunol 1998; 160: 1181-90.
80. Martin S, et al. Peptide immunization indicates that CD8+ T cells are the dominant effector cells in trinitrophenyl-specific contact hypersensitivity. J Invest Dermatol 2000; 115: 260-6.
81. Xu H, Dilulio NA, Fairchild RL. T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma-producing (Tc1) effector CD8+ T cells and interleukin (II) 4/II-10-producing (Th2) negative regulatory CD4+ T cells. J Exp Med 1996; 183: 1001-12.
82. Xu H, Bonerjee A, Dilulio NA, Fairchild RL. Development of effector CD8+ T cells in contact hypersensitivity occurs independently of CD4+ T cells. J Immunol 1997; 158: 4721-8.
83. Matzinger P. The danger model: a renewed sense of self. Science 2002; 296: 301-5.
84. Wang B, et al. Multiple paths for activatian of naive CD8+ T cells: CD4+-independent help. J Immunol 2001; 167: 1283-9.
85. Martin S, et al. A high frequency of allergen-specific CD8+ Tc1 cells is associated with the murine immune response to the contact sensitizer trinitraphenyl. Exp Dermatol 2003; 12: 78-85.
86. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401: 708-12.
87. Santamaria-Babi LF. CLA+ T cells in cutaneous diseases. Eur J Dermatol 2004; 14: 13-8.
88. Dudda JC, Simon JC, Martin S. Dendritic cell immunization route determines CD8+ T cell trafficking to inflamed skin: role for tissue microenvironment and dendritic cells in establishment of T cell-homing subsets. J Immunol 2004; 172: 857-63.
89. Berg EL, et al. The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell-leukocyte adhesion molecule 1. J Exp Med 1991; 174: 1461-6.
90. Campbell JJ, et al. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 1999; 400: 776-80.
91. Erdmann I, et al. Fucosyltransferase VII-deficient mice with defective E-, P-, and L-selectin ligands show impaired CD4+ and CD8+ T cell migration into the skin, but normal extravasation into visceral organs. J Immunol 2002; 168: 2139-46.
92. Reiss Y, Proudfoot AE, Power CA, Campbell JJ, Butcher EC. CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin. J Exp Med 2001; 194: 1541-7.
93. Santomorio LF, Perez Soler MT, Hauser C, Blaser K. Allergen specificity and endothelial transmigration of T cells in allergic contact dermatitis and otopic dermatitis are associated with the cutaneous lymphocyte antigen. Int Arch Allergy Immunol 1995; 107: 359-62.
94. Enk AH, Katz SI. Early molecular events in the induction phase of contact sensitivity. Proc Natl Acad Sci U S A 1992; 89: 1398-402.
95. Heufler C, et al. Cytokine gene expression in murine epidermal cell suspensions: interleukin 1 beta and macrophage inflammatory protein 1 alpha are selectively expressed in Langerhans cells but are differentially regulated in culture. J Exp Med 1992; 176: 1221-6.
96. Akiba H, et al. Skin inflammation during contact hypersensitivity is mediated by early recruitment of CD8+T cytotoxic 1 cells inducing keratinocyte opoptosis. J Immunol 2002; 168: 3079-87.
97. Albanesi C, et al. A cytokine-to-chemokine axis between T lymphocytes and keratinocytes can favor Th1 cell accumulation in chronic inflammatory skin diseases. J Leukoc Biol 2001; 70: 617-23.
98. Bonecchi R, et al. Differential expression of chemokine receptors and chemotoctic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998; 187: 129-34.
99. Flier J, et al. The CXCR3 activating chemokines IP-10, Mig, and IP-9 are expressed in allergic but not in irritant patch test reactions. J Invest Dermatol 1999; 113: 574-8.
100. Dufour JH, et al. IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol 2002; 168: 3195-204.
101. Homey B, et al. Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC). J Immunol 2000; 164: 3465-70.
102. Homey B, et al. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med 2002; 8: 157-65.
103. Cher DJ, Mosmann TR. Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones. J Immunol 1987; 138: 3688-94.
104. Gawkrodger DJ, Vestey JP, Wong WK, Buxton PK. Contact clinic survey of nickel-sensitive subjects. Contact Dermatitis 1986; 14: 165-9.
105. Silvennoinen-Kassinen S, Ikaheimo I, Karvonen J, Kauppinen M, Kallioinen M. Mononuclear cell subsets in the nickel-allergic reaction in vitro and in vivo. J Allergy Clin Immunol 1992; 89: 794-800.
106. Cavani A, Albanesi C, Traidl C, Sebastiani S, Girolomoni G. Effector and regulatory T cells in allergic contact dermatitis. Trends Immunol 2001; 22: 118-20.
107. Biedermann T, et al. Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J Exp Med 2000; 192: 1441-52.
108. Saulnier M, Huang S, Aguet M, Ryffel B. Role of interferon-gamma in contact hypersensitivity assessed in interferon-gamma receptor-deficient mice. Toxicology 1995; 102: 301-12.
109. Kehren J, et al. Cytotoxicity is mandatory for CD8+(+) T cell-mediated contact hypersensitivity. J Exp Med 1999; 189: 779-86.
110. Traidl C, et al. Disparate cytotoxic activity of nickel-specific CD8+ and CD4+ T cell subsets against keratinocytes. J Immunol 2000; 165: 3058-64.
111. Trautmann A, Akdis M, Brocker EB, Blaser K, Akdis CA. New insights into the role of T cells in otopic dermatitis and allergic contact dermatitis. Trends Immunol 2001; 22: 530-2.
112. Wagner L, et al. Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans. Nature 1998; 391: 908-11.
113. Gorbachev AV, Fairchild RL. CD4+(+) T Cells Regulate CD8+(+) T Cell-Mediated Cutaneous Immune Responses by Restricting Effector T Cell Development through a Fas Ligand-Dependent Mechanism. J Immunol 2004; 172: 2286-95.
114. Dubois B, Chapat L, Goubier A, Kaiserlian D. CD4+CD25+ T cells as key regulators of immune responses. Eur J Dermatol 2003; 13: 111-6.
115. Gorbachev AV, Fairchild RL. Regulatory role of CD4+ T cells during the development of contact hypersensitivity responses. Immunol Res 2001; 24: 69-77.
116. Gorbachev AV, Fairchild RL. Induction and regulation of T-cell priming for contact hypersensitivity. Crit Rev Immunol 2001; 21: 451-72.
117. Dubois B, et al. Innate CD4+CD25+ regulatory T cells are required for oral tolerance and control CD8+ T cells mediating skin inflammation. Blood 2003; 102:3295-330.
118. Ruckert R, Brandt K, Hofmann U, Bulfone-Paus S, Paus R. IL-2-IgG2b fusion protein suppresses murine contact hypersensitivity in vivo. J Invest Dermatol 2002; 119: 370-6.
119. Ferguson TA, Dube P, Griffith TS. Regulation of contact hypersensitivity by interleukin 10. J Exp Med 1994; 179: 1597-604.
120. Sebastioni S, et al. Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity. J Immunol 2001; 166: 996-1002.
121. Enk AH, Katz SI. Identification and induction of keratinocyte-derived IL-10. J Immunol 1992; 149: 92-5.
122. Melrose J, Tsurushita N, Liu G, Berg EL. IFN-gamma inhibits activation-induced expression of E- and P-selectin on endothelial cells. J Immunol 1998; 161: 457-64.
123. Kanervo L, Alanko K. Allergic contact dermatitis from 2-hydroxyethyl methocrylote in an adhesive on an electrosurgical earthing plate. Eur J Dermatol 1998; 8: 521-4.
124. von der Volk PG, Devos SA, Coenraads PJ. Evidence-based diagnosis in patch testing. Contact Dermatitis 2003; 48: 121-5.
125. Suneja T, Belsito DV. Comparative study of Finn Chambers and T.R.U.E. test methodologies in detecting the relevant allergens inducing contact dermatitis. J Am Acad Dermatol 2001; 45: 836-9.
126. Lochopelle JM, et al. Proposal for a revised international standard series of patch tests. Contact Dermatitis 1997; 36: 121-3.
127. Loffler H, et al. Evaluation of skin susceptibility to irritancy by routine patch testing with sodium lauryl sulfate. Eur J Dermatol 2001; 11: 416-9.
128. Fregert S. Manual of Contact Dermatitis. ed. 2. Copenhagen: Munksgaord; 1981.
129. Lachapelle JM. A proposed relevance scoring system for positive allergic patch test reactions: practical implications and limitations. Contact Dermatitis 1997; 36: 39-43.
130. Bruze M. What is a relevant contact allergy? Contact Dermatitis 1990; 23: 224-5.
131. Menne T. Prevention of nickel allergy by regulation of specific exposures. Ann Clin Lab Sci 1996; 26: 133-8.
132. Jensen CS, Lisby S, Baadsgaard O, Volund A, Menne T. Decrease in nickel sensitization in a Danish schoolgirl population with ears pierced after implementation of a nickel-exposure regulation. Br J Dermatol 2002; 146: 636-42.
133. Schnuch A, Geier J, Lessmann H, Uter W. Decrease in nickel sensitization in young patients-successful intervention through nickel exposure regulation? Results of IVDK, 1992-2001. Hautarzt 2003; 54: 626-32.
134. Goossens A, et al. Adverse cutaneous reactions to cosmetic allergens. Contact Dermatitis 1999; 40: 112-3.
135. De Groot AC. Fatal attractiveness: the shady side of cosmetics. Clin Dermatol 1998; 16: 167-79.
136. Hatch KL, Maibach HI. Textile dye allergic contact dermatitis prevalence. Contact Dermatitis 2000; 42: 187-95.
137. Rocha N, Silva E, Horta M, Massa A. Contact allergy to topical corticosteroids 1995-2001. Contact Dermatitis 2002; 47: 362-3.
138. Corazza M, Mantovani L, Maranini C, Bacilieri S, Virgili A. Contact sensitization to corticosteroids: increased risk in long term dermatoses. Eur J Dermatol 2000; 10: 533-5.
139. Veien NK, Hattel T, Laurberg G. Low nickel diet: an open, prospective trial. J Am Acad Dermatol 1993; 29: 1002-7.
140. Saripalli YV, Gadzia JE, Belsito DV. Tacrolimus ointment 0.1% in the treatment of nickel-induced allergic contact dermatitis. J Am Acad Dermatol 2003; 49: 477-82.
141. Ruzicka T, Assmann T, Lebwohl M. Potential future dermotological indications for tacrolimus ointment. Eur J Dermatol 2003; 13: 331-42.
142. Marsland AM, Griffiths CE. The macrolide immunosuppressants in dermatology: mechanisms of action. Eur J Dermatol 2002; 12: 618-22.